RIVA-TENOFOVIR
Identification of Riva-Tenofovir
| No description |
Google image searchProduct monograph
Active ingredient
tenofovir disoproxil fumarate, 300 MG
DIN: 02515156
Dosage form(s): TABLET
Route(s) of administration: ORAL
Schedule: Prescription
Company: LABORATOIRE RIVA INC.
Date: 14-JUN-2021
ATC:
- J05 — ANTIVIRALS FOR SYSTEMIC USE (ATC, ATC/DDD, )
- J05A — DIRECT ACTING ANTIVIRALS (ATC, ATC/DDD)
- J05AF — Nucleoside and nucleotide reverse transcriptase inhibitors (ATC, ATC/DDD)
- J05AF07 — TENOFOVIR DISOPROXIL (ATC/DDD)
Reference brand drug: Viread
Pharmaceutical standard: MFR
